Patient Characteristics

N (%)

Scans

N (%)

Clinical Indications

Staging

17 (39%)

Positive Scans

41 (93%)

Biochemical Recurrence

15 (34%)

Negative Scans

3 (7%)

Restaging after therapy

12 (27%)

Lesions*

Age (years)

Range: 48 - 84 years, Mean: 69.18 ± 7.35 years

≤50

1 (2%)

Prostatic Fossa Involvement

(T stage)

34 (83%)

T2u

13 (38%)

51 - 60

3 (7%)

61 - 70

26 (59%)

T2m

03 (9%)

71 - 80

11 (25%)

T3b

09 (26%)

≥81

3 (7%)

T4

07 (21%)

Serum PSA Level (ng/ml)

Range: <0.025 - 544 ng/ml, Median 12.3 ± 103 ng/ml

≤10

23 (52%)

Regional Nodal Involvement

(N stage)

17 (41%)

N1

05 (29%)

11 - 20

7 (16%)

21 - 100

9 (20%)

N2

11 (65%)

≥101

5 (11%)

Distant Metastasis

(M stage)

23 (56%)

M1a

11 (48%)

Gleason Score

<7

1 (2%)

7

22 (50%)

M1b

17 (74%)

8

15 (34%)

M1c

05 (22%)

≥9

6 (14%)